(Q46565002)

23 December 2017

title

Titrating steroids on exhaled nitric oxide in children with asthma: a randomized controlled trial (English)

1 reference

23 December 2017

0 references

4

Johan C De Jongste

1 reference

23 December 2017

author name string

Mariëlle W Pijnenburg

series ordinal

1

1 reference

23 December 2017

E Marije Bakker

series ordinal

2

1 reference

23 December 2017

Wim C Hop

series ordinal

3

1 reference

23 December 2017

language of work or name

English

0 references

publication date

23 June 2005

1 reference

23 December 2017

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

23 December 2017

volume

172

1 reference

23 December 2017

issue

7

1 reference

23 December 2017

page(s)

831-836

1 reference

23 December 2017

Airway inflammation is present during clinical remission of atopic asthma.

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

The magnitude of fear of adverse effects as a reason for nonparticipation in drug treatment: a short review

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Correlations between exhaled nitric oxide levels, blood eosinophilia, and airway obstruction reversibility in childhood asthma are detectable only in atopic individuals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Relationship of exhaled nitric oxide to clinical and inflammatory markers of persistent asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Clinical control and histopathologic outcome of asthma when using airway hyperresponsiveness as an additional guide to long-term treatment. The AMPUL Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Expired nitric oxide as a marker for childhood asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Exhaled markers of pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Airway nitrogen oxide measurements in asthma and other pediatric respiratory diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in children with difficult asthma, after treatment with oral prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

A single dose of nebulized budesonide decreases exhaled nitric oxide in children with acute asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Measurement of exhaled nitric oxide in children, 2001.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Steroid-naive adolescents with mild intermittent allergic asthma have airway hyperresponsiveness and elevated exhaled nitric oxide levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Outgrown asthma does not mean no airways inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Longitudinal study of grass pollen exposure, symptoms, and exhaled nitric oxide in childhood seasonal allergic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Exhaled nitric oxide predicts asthma relapse in children with clinical asthma remission

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Use of exhaled nitric oxide measurements to guide treatment in chronic asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Measurements of exhaled nitric oxide in healthy subjects age 4 to 17 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

A longitudinal, population-based, cohort study of childhood asthma followed to adulthood

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Risk factors for airway remodeling in asthma manifested by a low postbronchodilator FEV1/vital capacity ratio: a longitudinal population study from childhood to adulthood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Exhaled nitric oxide reflects asthma severity and asthma control

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Changes of exhaled nitric oxide during steroid treatment of childhood asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Inhaled corticosteroids for asthma therapy: patient compliance, devices, and inhalation technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

Airway Inflammation in Childhood Asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200503-458OC

10.1164/RCCM.200503-458OC

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

PubMed ID

15976380

1 reference

23 December 2017